Gene · 9965
Papers4,178
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
81 to 100 of 4,178
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Gut microbiome and bile acid metabolism in liver disease: Mechanisms, clinical implications, and therapeutic opportunities. | Pharmacol Rev | 2026 | 41759374 | PubTator, text mining | PubMed |
| Regulated cell death in sepsis-associated liver injury: molecular mechanisms and therapeutic implications. | Front Immunol | 2026 | 41756287 | PubTator, text mining | PubMed |
| Diet and Gut Microbiota in Inflammatory Bowel Disease: A Clinical and Nutritional Perspective. | Pharmaceuticals (Basel) | 2026 | 41754858 | PubTator, text mining | PubMed |
| The Gut-Liver Axis in MASLD: From Host-Microbiome Crosstalk to Precision Therapeutics. | Microorganisms | 2026 | 41753757 | PubTator, text mining | PubMed |
| From Childhood to Old Age: Current Knowledge and Practical Approaches to Metabolic Dysfunction-Associated Steatotic Liver Disease. | J Clin Med | 2026 | 41753223 | PubTator, text mining | PubMed |
| Weight Loss by Diet Versus Metabolic Surgery Increases Circulating NT-proANP in Obese Individuals. | J Clin Med | 2026 | 41753203 | PubTator, text mining | PubMed |
| MASLD Under the Umbrella of the Microbiota: A Narrative Review on Ecological Risk and Functional Transmissibility. | J Clin Med | 2026 | 41753013 | PubTator, text mining | PubMed |
Interactions Between the Gut Microbiome and Genetic and Clinical Risk Factors for Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) in Patients with Type 2 Diabetes Mellitus from Different Geographical Regions of Argentina. | Life (Basel) | 2026 | 41752919 | PubTator, text mining | PubMed |
| MASH in Type 2 Diabetes: Pathophysiology, Diagnosis, and Therapeutic Management-A Narrative Review. | Medicina (Kaunas) | 2026 | 41752724 | PubTator, text mining | PubMed |
| Functional Foods as Modulators of Epigenetic Mechanisms Affecting Metabolic Health in Adolescence. | Int J Mol Sci | 2026 | 41752200 | PubTator, text mining | PubMed |
| Associations Between Klotho/FGF-Related Protein Expression in Peripheral Blood Mononuclear Cells, Inflammation, and Muscle Function in Middle-Aged Adults with Obesity: A Pilot Study. | Int J Mol Sci | 2026 | 41752116 | PubTator, text mining | PubMed |
| The Impact of Hyperphosphatemia on Mineral and Bone Metabolism: Implications for Bone and Vascular Health. | Int J Mol Sci | 2026 | 41752068 | PubTator, text mining | PubMed |
| Feedback Regulation of Pancreatic Juice Secretion in Pigs. | Biomolecules | 2026 | 41750390 | PubTator, text mining | PubMed |
| Hydrogel-Based Therapeutic Strategies for Post-Cholecystectomy NAFLD: Targeting Bile Acid Signaling, Gut Microbiota, Inflammation, and Hepatic Fibrosis. | Gels | 2026 | 41745051 | PubTator, text mining | PubMed |
| The Role of Plant-Based Diets for Cancer Survivors and Planetary Health. | Curr Oncol | 2026 | 41744837 | PubTator, text mining | PubMed |
| Comparing the impact of sample multiplexing approaches for single-cell RNA-sequencing on downstream analysis using cerebellar organoids. | iScience | 2026 | 41743667 | PubTator, text mining | PubMed |
| Metabolic, enterohepatic and gut microbial effects of atorvastatin in healthy men. | Endocr Connect | 2026 | 41738774 | PubTator, text mining | PubMed |
| FXR in bone metabolism: An emerging regulator. | iScience | 2026 | 41732262 | PubTator, text mining | PubMed |
| Pleiotropic immunoregulation by bile acids in pathophysiology. | Front Immunol | 2026 | 41727485 | PubTator, text mining | PubMed |
| Pediatric Cholestatic Diseases in the Era of Ileal Bile Acid Transporter (IBAT) Inhibitors. | Pediatr Rep | 2026 | 41718432 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/9965/papers?page=5